Dr. Maria Coco, MD

Dr. Coco practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Coco's NPI, 1649360546, was assigned on October 13, 2006. Dr. Coco holds New York license 162534.

Dr. Coco's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Coco's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Coco to 1 more dialysis center and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coco practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Coco's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Coco is licensed in New York.

CMS data shows 535 Medicare services from Dr. Coco across 8 procedure codes in 2024, for 221 Medicare patients. Medicare paid $65,002 for them.

CMS counts 221 Medicare patients who saw Dr. Coco in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 68% are also on Medicaid. Their average risk score is 6.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Coco's median patient age at 70, with 48% women.

In 2024, Dr. Coco wrote 746 Medicare Part D claims for 118 patients. 88% of them were for generic drugs. CMS names the drug for 589 of them, across 22 drugs with 11 or more claims each, at $91,504 in total drug cost. In 2023, CMS named 539 claims across 23 drugs.

CMS lists Dr. Coco as offering telehealth.

Dmand AI links 14 papers to Dr. Coco, published from 2003 to 2021. 2020 was the busiest year, with 4. The most frequent topics are COVID-19, Kidney Transplantation and Renal Dialysis. Dr. Coco has published most often in Kidney360. Dr. Coco's most frequent co-authors are Michele H. Mokrzycki, MD, MS, Ladan Golestaneh, MD and Eran Y. Bellin, MD.

Dmand AI links Dr. Coco to 1 clinical trial. Conditions studied include Hypophosphatemia and Phosphorus Metabolism Disorders.

CMS Open Payments shows 6 general payments to Dr. Coco from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Mallinckrodt Enterprises LLC paid the most, $75.